These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

144 related articles for article (PubMed ID: 22279861)

  • 1. [Pathophysiological mechanisms and treatment of septic shock-induced vasoplegia].
    Jeanneret S; Sanchez B; Liaudet L
    Rev Med Suisse; 2011 Dec; 7(321):2435-8. PubMed ID: 22279861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Vasoplegia in septic shock (review).
    Gamcrlidze MM; Intskirveli NA; Vardosanidze KD; Chikhladze KhE; Goliadze LSh; Ratiani LR
    Georgian Med News; 2015 Feb; (239):56-62. PubMed ID: 25802451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Vasoplegia in septic shock: do we really fight the right enemy?
    Sharawy N
    J Crit Care; 2014 Feb; 29(1):83-7. PubMed ID: 24095623
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mechanisms of vascular hyporesponsiveness in septic shock.
    Kimmoun A; Ducrocq N; Levy B
    Curr Vasc Pharmacol; 2013 Mar; 11(2):139-49. PubMed ID: 23506493
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The Story of Nitric Oxide, Sepsis and Methylene Blue: A Comprehensive Pathophysiologic Review.
    Saha BK; Burns SL
    Am J Med Sci; 2020 Oct; 360(4):329-337. PubMed ID: 32631574
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The current management of septic shock.
    Russel JA
    Minerva Med; 2008 Oct; 99(5):431-58. PubMed ID: 18971911
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular hyporesponsiveness to vasopressors in septic shock: from bench to bedside.
    Levy B; Collin S; Sennoun N; Ducrocq N; Kimmoun A; Asfar P; Perez P; Meziani F
    Intensive Care Med; 2010 Dec; 36(12):2019-29. PubMed ID: 20862451
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Vasoplegic syndrome and its treatment with vasopressin during cardiac surgery with cardiopulmonary bypass].
    Gilbert M; Lema G
    Rev Med Chil; 2011 Mar; 139(3):368-72. PubMed ID: 21879171
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vasoplegia After Cardiovascular Procedures-Pathophysiology and Targeted Therapy.
    Shaefi S; Mittel A; Klick J; Evans A; Ivascu NS; Gutsche J; Augoustides JGT
    J Cardiothorac Vasc Anesth; 2018 Apr; 32(2):1013-1022. PubMed ID: 29223724
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of vasopressin in septic shock.
    Ruggiero MS
    AACN Adv Crit Care; 2008; 19(3):281-7. PubMed ID: 18670203
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Vasoplegic shock during liver transplantation: is the preoperative cGMP plasma level a potential predictor of hemodynamic instability?
    Bezinover D; McQuillan P; Rossignol J; Uemura T; Kadry Z; Janicki P
    Med Sci Monit; 2010 Sep; 16(9):CS114-7. PubMed ID: 20802421
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Vasoplegia treatments: the past, the present, and the future.
    Levy B; Fritz C; Tahon E; Jacquot A; Auchet T; Kimmoun A
    Crit Care; 2018 Feb; 22(1):52. PubMed ID: 29486781
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vasoplegia: A Review.
    Ratnani I; Ochani RK; Shaikh A; Jatoi HN
    Methodist Debakey Cardiovasc J; 2023; 19(4):38-47. PubMed ID: 37547893
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Vasoplegia in patients with sepsis and septic shock: pathways and mechanisms.
    Burgdorff AM; Bucher M; Schumann J
    J Int Med Res; 2018 Apr; 46(4):1303-1310. PubMed ID: 29332515
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Catecholamines and vasopressin during critical illness.
    Bassi G; Radermacher P; Calzia E
    Endocrinol Metab Clin North Am; 2006 Dec; 35(4):839-57, x. PubMed ID: 17127150
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular events in the cardiomyopathy of sepsis.
    Flierl MA; Rittirsch D; Huber-Lang MS; Sarma JV; Ward PA
    Mol Med; 2008; 14(5-6):327-36. PubMed ID: 18256728
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Role of peroxynitrite in the cardiovascular dysfunction of septic shock.
    Liaudet L; Rosenblatt-Velin N; Pacher P
    Curr Vasc Pharmacol; 2013 Mar; 11(2):196-207. PubMed ID: 23506498
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Perivascular adipose tissue contributes to lethal sepsis-induced vasoplegia in rats.
    Awata WMC; Gonzaga NA; Borges VF; Silva CBP; Tanus-Santos JE; Cunha FQ; Tirapelli CR
    Eur J Pharmacol; 2019 Nov; 863():172706. PubMed ID: 31568782
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Science Review: Vasopressin and the cardiovascular system part 2 - clinical physiology.
    Holmes CL; Landry DW; Granton JT
    Crit Care; 2004 Feb; 8(1):15-23. PubMed ID: 14975041
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Randomized, double-blind, placebo-controlled crossover pilot study of a potassium channel blocker in patients with septic shock.
    Warrillow S; Egi M; Bellomo R
    Crit Care Med; 2006 Apr; 34(4):980-5. PubMed ID: 16484892
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.